Chick optic lobe contains a developmentally regulated α2α5β2 nicotinic receptor subtype

被引:28
作者
Balestra, B
Vailati, S
Moretti, M
Hanke, W
Clementi, F
Gotti, C
机构
[1] Univ Milan, Dept Med Pharmacol, CNR, Cellular & Mol Pharmacol Ctr, I-20129 Milan, Italy
[2] Univ Hohenheim, Inst Zoophysiol, D-7000 Stuttgart, Germany
关键词
D O I
10.1124/mol.58.2.300
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The most widely expressed neuronal nicotinic acetylcholine receptor subtype in chick brain is that containing the alpha 4 and beta 2 subunits. However, immunoprecipitation and localization studies have shown that some brain areas also contain the alpha 2 and/or alpha 5 subunits, whose role in the definition of receptor properties is still intriguing. Using subunit-specific polyclonal antibodies, we found that the optic lobe is the chick central nervous system region that expresses the highest level of alpha 2-containing receptors. Immunoprecipitation studies of these immunopurified alpha 2-containing receptors labeled with the nicotinic agonist [H-3]epibatidine showed that almost all of them contained the beta 2 subunit and that more than 66% contained the alpha 5 subunit. Western blot analyses of the purified receptors confirmed the presence of the alpha 2, alpha 5, and beta 2 subunits and the absence of the alpha 3, alpha 4, alpha 6, alpha 7, alpha 8, beta 3, and beta 4 subunits. The alpha 2-containing receptors are developmentally regulated: their expression increases 25 times from embryonic day 7 to post-hatching day 1 in the optic lobe, compared with an increase of only 5-fold in the forebrain. The alpha 2-containing optic lobe receptors bind [H-3]epibatidine (K-d = 29 pM) and a number of other nicotinic agonists with very high affinity and have a pharmacological profile very similar to that of the alpha 4 beta 2 subtype. They form functional cationic channels when reconstituted in lipid bilayers, with pharmacological and biophysical properties different from those of the alpha 4 beta 2 subtype. These channels are activated by nicotinic agonists in a dose-dependent manner and are blocked by the nicotinic antagonist d-tubocurarine.
引用
收藏
页码:300 / 311
页数:12
相关论文
共 40 条
[1]   EFFECTS OF RETINAL LESIONS UPON THE DISTRIBUTION OF NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNITS IN THE CHICK VISUAL-SYSTEM [J].
BRITTO, LRG ;
TORRAO, AS ;
HAMASSAKIBRITTO, DE ;
MPODOZIS, J ;
KEYSER, KT ;
LINDSTROM, JM ;
KARTEN, HJ .
JOURNAL OF COMPARATIVE NEUROLOGY, 1994, 350 (03) :473-484
[2]   THE ALPHA-5-GENE PRODUCT ASSEMBLES WITH MULTIPLE ACETYLCHOLINE-RECEPTOR SUBUNITS TO FORM DISTINCTIVE RECEPTOR SUBTYPES IN BRAIN [J].
CONROY, WG ;
VERNALLIS, AB ;
BERG, DK .
NEURON, 1992, 9 (04) :679-691
[3]   NEURONS CAN MAINTAIN MULTIPLE CLASSES OF NICOTINIC ACETYLCHOLINE-RECEPTORS DISTINGUISHED BY DIFFERENT SUBUNIT COMPOSITIONS [J].
CONROY, WG ;
BERG, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) :4424-4431
[4]   Nicotinic receptor subtypes in the developing chick brain:: Appearance of a species containing the α4, β2, and α5 gene products [J].
Conroy, WG ;
Berg, DK .
MOLECULAR PHARMACOLOGY, 1998, 53 (03) :392-401
[5]   COMPARISON OF NEURONAL NICOTINIC RECEPTORS IN RAT SYMPATHETIC NEURONS WITH SUBUNIT PAIRS EXPRESSED IN XENOPUS OOCYTES [J].
COVERNTON, PJO ;
KOJIMA, H ;
SIVILOTTI, LG ;
GIBB, AJ ;
COLQUHOUN, D .
JOURNAL OF PHYSIOLOGY-LONDON, 1994, 481 (01) :27-34
[6]   Molecular and cellular aspects of nicotine abuse [J].
Dani, JA ;
Heinemann, S .
NEURON, 1996, 16 (05) :905-908
[7]   DIFFERENTIAL EXPRESSION OF THE NEURONAL ACETYLCHOLINE RECEPTOR-ALPHA-2 SUBUNIT GENE DURING CHICK BRAIN-DEVELOPMENT [J].
DAUBAS, P ;
DEVILLERSTHIERY, A ;
GEOFFROY, B ;
MARTINEZ, S ;
BESSIS, A ;
CHANGEUX, JP .
NEURON, 1990, 5 (01) :49-60
[8]  
Forsayeth JR, 1997, J NEUROSCI, V17, P1531
[9]   alpha(5) subunit forms functional alpha(3)beta(4)alpha(5) nAChRs in transfected human cells [J].
Fucile, S ;
Barabino, B ;
Palma, E ;
Grassi, F ;
Limatola, C ;
Mileo, AM ;
Alema, S ;
Ballivet, M ;
Eusebi, F .
NEUROREPORT, 1997, 8 (11) :2433-2436
[10]   NEURONAL NICOTINIC RECEPTORS - MOLECULAR-ORGANIZATION AND REGULATIONS [J].
GALZI, JL ;
CHANGEUX, JP .
NEUROPHARMACOLOGY, 1995, 34 (06) :563-582